Page 2 - Genscript Probio News Today

PISCATAWAY, N.J. & NEW YORK--(BUSINESS WIRE)--GenScript ProBio, a global contract development and manufacturing organization, and Comprehensive Cell Solutions (CCS), a leader in cell therapy development and manufacturing, have partnered to spearhead the development of cell and gene therapies, offering a unique and s...

A period of continued significant progress Avacta Group plc , a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to... | April 25, 2023

In this GEN webinar, our distinguished speaker, Dr. Ming Ni, will discuss GenScript ProBio’s plasmid platform technologies designed for producing plasmid DNA in high yields using advanced methodologies.

PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on

A slew of industry and institutional investors have participated in PCG Power's funding round.

/PRNewswire/ -- GenScript ProBio, a leading Biologics CDMO to the bio-pharmaceutical market, and Bio Immunitas, a UK pharmaceutical company with a novel, safe...

SK Bioscience, developer of SKYCovione, Koreas first COVID-19 vaccine, has recruited renowned executives who have worked for global biopharmaceutical companies as part of its efforts to advance into the global market and diversify, according to the company, Friday. The company said it appointed Richard Kensinger as vice president of R&D project management at its U.S. branch, SK Bioscience USA.

/PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure across the globe,...

The Series C deal, upon closing, would dilute GenScript Biotech's stake in Probio Cayman.

/PRNewswire/ -- The "Global Biosimilars Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.coms offering. The Global...